
Talha Badar/X
Mar 1, 2025, 12:10
Talha Badar: Up-front Blinatumomab Improves MRD Clearance and Outcome in Adult Ph− B-lineage ALL
Talha Badar, Hematology Oncology based in Mayo Clinic, shared an article by Renato Bassan, et al. on X:
“Up-front Blinatumomab Improves MRD Clearance and Outcome in Adult Ph− B-lineage ALL: the GIMEMA LAL2317 Phase 2 Study.
Upfront Blina after C3 ad C6 of consolidation, risk-adapted. Primary endpoint MRD-ve CR Results: 93% MRD-ve, 3 yrs OS blina treated pts 91%.”
Up-front Blinatumomab Improves MRD Clearance and Outcome in Adult Ph− B-lineage ALL: the GIMEMA LAL2317 Phase 2 Study.
Authors: Renato Bassan, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 12:48
Apr 1, 2025, 12:16
Apr 1, 2025, 12:13
Apr 1, 2025, 12:07
Apr 1, 2025, 11:53